DOGAN LAB
Mission Statement:
- To develop an immunomodulatory strategy to enhance long-term survival and immune protection of transplanted allogeneic islets in T1D diabetic mouse models, eliminating the need for systemic immunosuppression.
- To engineer a Pre-vascularized Subcutaneous Site for non-Invasive Allogeneic Islet Transplantation
- To develop a safe, islet-targeted non-viral gene delivery system using Nano2transfection to restore and immune-protect residual beta-cell mass, enabling early-stage T1D treatment and prevention.
Research Focus:
The Dogan Laboratory pioneers the development of immunomodulatory therapies and pre-vascularized, non-invasive transplant sites to enable allogeneic islet transplantation without systemic immunosuppression in T1D. In parallel, the lab develops a novel, safe, and islet-targeted gene delivery system to restore and immune-protect pancreatic islets targeting the early stage of disease.
VIC Projects List
- Combining pre-vascularized subcutaneous transplant approaches to achieve enhanced immunoprotection and support of transplanted allogeneic islets without systemic immunosuppression to cure T1D.
- Improving beta cell survival and function in transplant location through immunomodulatory tissue-protective B cell therapy in T1D.
- Leveraging Imaging Mass Cytometry (IMC) to investigate immune cell composition and cell-cell interactions within the islet graft microenvironment to discover novel targets for graft acceptance.
- Delivering non-viral, targeted therapeutic cargo to pancreatic islets using Nano2transfection technology, with potential for clinical translation and large-scale economic application.
- Targeting the proinsulin processing pathway to prevent and/or reverse T1D.
Highlighted Publications
Combinatorial islet protective therapeutic approaches in β-cell transplantation: Rationally designed solutions using a target product profile.
Telomerase Regulation: A Role for Epigenetics.
DNMT3B Is an Oxygen-Sensitive De Novo Methylase in Human Mesenchymal Stem Cells.
Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin-Based Dermal Matrix Combined with Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers.
The effect of ICRT-3 on Wnt signaling pathway in head and neck cancer.
Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies.
Investigation of the Effect of Telomerase Inhibitor BIBR1532 on Breast Cancer and Breast Cancer Stem Cells.
Correlation between Telomerase and mTOR Pathway in Cancer Stem Cells.


Research Team
Ghazel Mukhtar, MD
Research Student
Shuwen Liu, MD Student
Research Student
Shina Kintu
Research Student
Almas Shaikh, MSc
Research Lab Technician
Valentina Giai, PhD Student – University of Edinburgh (Research Student)
Sitong (Steve) Ye, MSc – Yale University, New Haven (Research Lab Technician)
Assia El Babsiri, MSc – University of Paris, Faculty of Pharmacy (Research Student)
Ben Shaer, BS candidate, MIT (high school research student)
Jihra James, BS candidate, Langston University (Research Student)
Esin Ozkan, MD – Bezmialem Vakif University, Türkiye (Research Student)
Aaruni Arora, MEng – Imperial College London (Research Student)
Katie Lu, MD Student – UCSF, San Francisco (Research Student)

